Grant: Collaborative Research and Development Grants
University of Guelph
$51,173.00
Effect of targeted selective treatement with closantel at lambing in haemonchus burdens on Ontario sheep farms with anthelmintic resistance
EF 2013-14
Résumé
Haemonchus contortus is increasingly being recognised as a significant constraint to sheep production on pasture in Ontario; it is a significant cause of morbidity and mortality in lambs and adult sheep from the effects of profound anaemia and hypoproteinemia. Recent work in the province has demonstrated a high prevalence of resistance in this parasite to the two most commonly used anthelmintics in sheep, i.e. resistance to ivermectin and fenbendazole has been demonstrated on >90% of tested farms. Only ivermectin is approved for use in sheep, and benzimidazoles (i.e. fenbendazole and albendazole) are only available when used in an extra label manner. No other anthelmintics are available for use in sheep in Canada. As a result, farms with multiple drug resistance have no reasonable pharmaceutical alternatives for parasite treatment. Improved control strategies are therefore urgently required. This project will define the parameters that influence the infectivity of H. contortus on pasture and thus help enhance control programs for the parasite. In addition, via a proof of concept study, the ability of closantel (a narrow-spectrum anthelmintic with activity against H. contortus, not previously used in Canada) to control drug-resistant H. contortus infections will be assessed. Since ewes are the primary source of pasture contamination with H. contortus in the spring due to the periparturient egg rise induced by lambing and lactation, two treatment strategies for ewes at lambing will be evaluated, i.e. whole flock versus targeted selective treatment of ewes. Outcomes assessment will include ability of each treatment strategy to control infection and disease in the ewes and in their lambs, and to control contamination of grazing pastures - whilst not increasing the proportion of H. contortus showing resistance to closantel. The resultant data will help to generate novel strategies for controlling drug-resistant infections and for reducing anthelmintic use on sheep farms, thus contributing to more prudent use of anthelmintics in Ontario flocks. The data will also assist in the approval of a new anthelmintic for use in sheep in Canada.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
445788-2012
Name nom
Peregrine, Andrew
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
51173
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5508
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Parasitology
Research subject fr
Parasitologie
Partie
1
Nb partie
3
Application title
Effect of targeted selective treatement with closantel at lambing in haemonchus burdens on Ontario sheep farms with anthelmintic resistance
Keyword
NSERC
Application summary
Haemonchus contortus is increasingly being recognised as a significant constraint to sheep production on pasture in Ontario; it is a significant cause of morbidity and mortality in lambs and adult sheep from the effects of profound anaemia and hypoproteinemia. Recent work in the province has demonstrated a high prevalence of resistance in this parasite to the two most commonly used anthelmintics in sheep, i.e. resistance to ivermectin and fenbendazole has been demonstrated on >90% of tested farms. Only ivermectin is approved for use in sheep, and benzimidazoles (i.e. fenbendazole and albendazole) are only available when used in an extra label manner. No other anthelmintics are available for use in sheep in Canada. As a result, farms with multiple drug resistance have no reasonable pharmaceutical alternatives for parasite treatment. Improved control strategies are therefore urgently required. This project will define the parameters that influence the infectivity of H. contortus on pasture and thus help enhance control programs for the parasite. In addition, via a proof of concept study, the ability of closantel (a narrow-spectrum anthelmintic with activity against H. contortus, not previously used in Canada) to control drug-resistant H. contortus infections will be assessed. Since ewes are the primary source of pasture contamination with H. contortus in the spring due to the periparturient egg rise induced by lambing and lactation, two treatment strategies for ewes at lambing will be evaluated, i.e. whole flock versus targeted selective treatment of ewes. Outcomes assessment will include ability of each treatment strategy to control infection and disease in the ewes and in their lambs, and to control contamination of grazing pastures - whilst not increasing the proportion of H. contortus showing resistance to closantel. The resultant data will help to generate novel strategies for controlling drug-resistant infections and for reducing anthelmintic use on sheep farms, thus contributing to more prudent use of anthelmintics in Ontario flocks. The data will also assist in the approval of a new anthelmintic for use in sheep in Canada.